ARCHIVES

Moses To Lead AACI.

This article is from The Cancer Letter archive.

Vol. 27 No. 38 | October 19, 2001

Download PDF Visit The Full Archive

Related Articles

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

Racker Withdraws Some Claims Made In Science Article, Says Data Are “No Question A Mess”

September 11, 1981

Cytopathologists, NCI Recommend New Method For Pap Smear Reports

August 25, 1989

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

Cancer Deaths In Black Men Could Drop By Cutting Tobacco

April 30, 2004

DCPC Board Oks Concept For Three New Grant Programs, Three Contracts

May 22, 1987